Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea
· Delayed Price · Currency is KRW 14,020
0.00 (0.00%)
At close: Dec 5, 2025
Cell Biotech Revenue
Cell Biotech had revenue of 15.36B KRW in the quarter ending September 30, 2025, with 26.25% growth. This brings the company's revenue in the last twelve months to 50.65B, down -3.71% year-over-year. In the year 2024, Cell Biotech had annual revenue of 49.91B, down -7.20%.
Revenue (ttm)
50.65B
Revenue Growth
-3.71%
P/S Ratio
1.89
Revenue / Employee
501.47M
Employees
101
Market Cap
95.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49.91B | -3.87B | -7.20% |
| Dec 31, 2023 | 53.79B | 3.26B | 6.46% |
| Dec 31, 2022 | 50.53B | 3.65B | 7.79% |
| Dec 31, 2021 | 46.87B | 1.29B | 2.83% |
| Dec 31, 2020 | 45.58B | -377.42M | -0.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |